ESR Secures US$850 Million to Accelerate Long-term Growth
April 10, 2026
Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across
MENA
ESR Secures US$850 Million to Accelerate Long-term Growth
April 10, 2026
Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across
ESR Secures US$850 Million to Accelerate Long-term Growth
April 10, 2026
Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across
ESR Secures US$850 Million to Accelerate Long-term Growth
April 10, 2026
Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across
ESR Secures US$850 Million to Accelerate Long-term Growth
April 10, 2026
Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across
ESR Secures US$850 Million to Accelerate Long-term Growth
April 10, 2026
Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
April 10, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
April 10, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
April 10, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
April 10, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
April 10, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
April 10, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers